key: cord-1018478-psg0j39k
authors: Issa, N.; Lacassin, F.; Camou, F.
title: First case of persistent pancytopenia associated with SARS-CoV-2 bone marrow infiltration in an immunocompromised patient
date: 2020-06-29
journal: Ann Oncol
DOI: 10.1016/j.annonc.2020.06.016
sha: 398ef806f86a4fa20b188ea2865602011b9f6687
doc_id: 1018478
cord_uid: psg0j39k

nan

If respiratory complications are the most common clinical presentation of severe COVID-19, hematological involvement as described here and persistent viremia are not published in the literature (1, 2) . SARS-CoV-2 RT-PCR should be performed in blood and bone marrow aspiration in case of pancytopenia associated with typical COVID-19 especially in case of secondary humoral immunodeficiency. Among the many therapeutic options under investigation, including antiviral drugs, we suggest that convalescent plasma could be useful in patients with COVID-19 infection and concurrent persistent B-cell immunodeficiency; we will consider this approach for our patient (3) (4) (5) .

Severe Covid-19

Impacts of immunosuppression and immunodeficiency on COVID-19: a systematic review and meta-analysis. The Journal of infection

Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review. The Cochrane database of systematic reviews

Why should we use convalescent plasma for COVID-19? European journal of internal medicine

Crossneutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

Funding: none declared Disclosure: the authors have declared no conflicts of interest